Abstract
Twenty-two patients with small-cell carcinoma of the lung who had failed combination chemotherapy were treated with VP-16-213 as a single agent. A partial remission was achieved in one patient. Twenty-three percent of the patients experienced arrest of disease for a median of 31 weeks. Leukopenia was a major complicating side effect.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 155-157 |
| Number of pages | 3 |
| Journal | Cancer Clinical Trials |
| Volume | 4 |
| Issue number | 2 |
| State | Published - 1981 |
ASJC Scopus subject areas
- Medicine(all)